MedPath

Optimization of exercise therapy in type 2 diabetes mellitus.

Conditions
Insulin resistance, endothelial dysfunction, cardiovascular fitness, cardio-respiratory responses, glycemic control indeconditioned non-insulin dependent type 2 diabetes patients
Therapeutic area: Body processes [G] - Physiological processes [G07]
Registration Number
EUCTR2011-006237-42-NL
Lead Sponsor
Erasmus University Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

•Type 2 Diabetes Mellitus >3 months.
•Age: 40-65 years.
•BMI between 27 and 35 kg/m2.
•Formal permission to participate in the study by signing an informed consent form.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 12
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Cardiovascular disease: objective heart failure (ejection fraction <35%), electrocardiographically diagnosed cardiac ischemia or symptomatic peripheral vascular disease diagnosed by Doppler ultrasound investigation
•Serious orthopedic of neurological conditions precluding an exercise test.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath